克里斯普尔-AuNP:金纳米粒子平台的物理化学优化,用于HSPC中具有成本效益和模块化的非病毒基因编辑
Karthikeya S V Gottimukkala1,2, Daniel D Lane1,2, Rachel Cunningham1,2
1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Gene therapy
|January 14, 2026
概括
研究人员开发了一种新型的金聚合物纳米粒子,用于在造血干细胞 (HSPC) 中进行CRISPR基因编辑. 这种具有成本效益的快速方法提高了治疗应用的HSPC中CRISPR传递效率.
科学领域:
- 生物技术是生物技术.
- 纳米技术 纳米技术
- 基因编辑 基因编辑
背景情况:
- 在基因编辑疗法中,有效地将CRISPR核核蛋白传递到造血干细胞和原生细胞 (HSPC) 中至关重要.
- 目前的HSPC非病毒传递方法在效率和可扩展性方面面临挑战.
研究的目的:
- 开发一个模块化,台式组装的金聚合物混合纳米粒子 (CRISPR-AuNP) 平台,用于向HSPC输送非病毒CRISPR.
- 在初级HSPC中设计一个具有成本效益和快速的纳米配方,以实现高效的基因编辑.
主要方法:
- 预先形成的RNP-聚合物复合物 (thiolated聚乙烯胺-聚乙烯甘醇) 与金纳米颗粒的结合.
- 利用对Cas9黄金表面相互作用的机械学理解,用于配方工程.
- 在初级CD34+HSPC中测试CRISPR-AuNP平台的Cas9,Cas12a和Cas12a-M29-1.
主要成果:
- 通过CRISPR-AuNP平台使用Cas9,Cas12a和Cas12a-M29-1实现了初级CD34+HSPC中的高效基因编辑.
- 在纳米粒子介导的输送后,细胞活力没有受到损害.
- 纳米配方组装在不到2小时内完成,花费不到7000万美元的HSPC处理.
结论:
- 该CRISPR-AuNP平台提供了一个可扩展,具有成本效益和可访问的方法,用于将CRISPR传输到HSPC中.
- 这项技术有可能在HSPC研究和治疗中推进CRISPR应用.
- 在初级干细胞中建立了多个CRISPR核酶的新型非病毒传递系统.
相关概念视频
CRISPR
46.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
46.6K
Homologous Recombination
58.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
58.9K
CRISPR and crRNAs
14.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
14.6K
CRISPR/Cas9 Genome Editing
3.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.2K


